Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q1 EPS of ($0.33), $0.08 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $2.17 million versus the consensus estimate of $7.69 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.